Inhibition of SARS Coronavirus Infection in Vitro with Clinically Approved Antiviral Drugs

• المؤلفون الرئيسيون: Tan, E.L.C, Ooi, E.E, Lin, C.-Y, Tan, H.C, Ling, A.E, Lim, B, Stanton, L.W
• مؤلفون آخرون: BIOLOGICAL SCIENCES
• التنسيق: مقال
• منشور في: Centers for Disease Control and Prevention (CDC) 2020
• الموضوعات: aciclovir; alpha interferon; alphan1 interferon; alphan3 interferon; amantadine; antivirus agent; beta1a interferon; foscarnet sodium; ganciclovir; human leukocyte interferon alpha; indinavir; interferon beta serine; lamivudine; multiferon; nelfinavir; nucleoside analog; oseltamivir; proteinase inhibitor; recombinant alpha2a interferon; recombinant alpha2b interferon; ribavirin; RNA directed DNA polymerase inhibitor; saquinavir; sialidase inhibitor; unclassified drug; zanamivir; zidovudine; animal cell; antiviral activity; article; controlled study; cytopathogenic effect; drug efficacy; drug screening; in vitro study; infection prevention; nonhuman; SARS coronavirus; severe acute respiratory syndrome; Vero cell; virus culture; virus load; virus plaque
• الوصول للمادة أونلاين: https://scholarbank.nus.edu.sg/handle/10635/181117
• المؤسسة: National University of Singapore

10.3201/eid1004.030458